Powered by

Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Business Update

Nov 07, 2017 - Business Wire

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today reported financial results for the third quarter and nine months ended September 30, 2017 and provided an update on business progress.

"During the third quarter of 2017, Kala strengthened its financial position by closing a successful initial public offering resulting in gross pr...